Information

Organizing committee:

Corine Bertolotto: C3M, INSERM U1065, Nice, France
Robert Ballotti: C3M, INSERM U1065, Nice, France

  1. Molecular mechanisms involved in ocular Melanoma
  2. New pathways/melanoma genes
  3. Emerging technologies for probing magnitude/dynamics of intra-tumor heterogeneity
  4. Tumor initiation, cell(s)-of-origin or animal model
  5. Non-genetic Intratumor Heterogeneity
  6. Progression & Metastasis (Metabolism, Micro-environment)
  7. Immunotherapy
  8. Therapy resistance
  • Corine BERTOLOTTO C3M, INSERM U1065, Nice, France
  • Robert BALLOTTI C3M, INSERM U1065, Nice, France
  • Colin GODING Ludwig Institute for Cancer Research, Oxford, UK
  • Eirikur STEINGRIMSSON University of Iceland, Reykjavik, Iceland
  • Lionel LARUE Curie Institute, Paris, France
  • Irwin DAVIDSON Institute of Genetics and Molecular and Cellular Biology, Strasbourg, France
  • Luisa LANFRANCONE European Institute of Oncology (IEO), Milan, Italy
  • Laurence NIETO University Paul Sabatier, Toulouse, France
  • Jean Christophe MARINE VIB, KU Leuven, Leuven, Belgium
  • Eleonora LEUCCI VIB, KU Leuven, Leuven, Belgium
  • Lukas SOMMER University of Zurich, Zurich, Switzerland
  • Elizabeth PATTON University of Edinburgh, Edinburgh, UK
  • Ze’ev RONAI Sanford Burnham Prebys Institute, San Diego, USA
  • Marisol SOENGAS National Cancer Research Center, CNIO, Madrid, Spain
  • Daniel PEEPER Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Marie-Dominique GALIBERT Institute of Genetics and Development, Rennes, France
  • Yardena SAMUELS Weizmann Institute of Science, Rehovot, Israel
  • Thierry PASSERON Nice Hospital, Nice, France
  • Emily BERNSTEIN Mount Sinai, New York, USA
  • Andrew APLIN Thomas Jefferson University, Philadelphia, USA
  • Pierre CLOSE University of Liege, Liege, Belgium
  • Marie-Laure YASPO Max Planck Institute for molecular genetics, Berlin, Germany

Sponsors

Le Saint Paul Hôtel 

29 boulevard Franck Pilatte
06300 Nice

Registration